What is the recommended starting dose of naltrexone for opioid dependence and for alcohol dependence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Starting Dose for Naltrexone

For opioid dependence, start with 25 mg once daily; if no withdrawal signs occur, increase to 50 mg daily thereafter. For alcohol dependence, start directly with 50 mg once daily. 1

Critical Pre-Treatment Requirements

Before initiating naltrexone, patients must be opioid-free to avoid precipitated withdrawal, which can be severe and potentially dangerous:

  • Minimum 7-10 days opioid-free for short-acting opioids
  • Up to 2 weeks for patients transitioning from buprenorphine or methadone 1
  • Consider naloxone challenge test if occult opioid dependence is suspected (IV: 0.2 mg, then 0.6 mg; or SC: 0.8 mg) 1

Warning: Patients switching from opioid agonist therapy (methadone, buprenorphine) may experience severe precipitated withdrawal. Healthcare providers must be prepared to manage withdrawal symptomatically with non-opioid medications. 1

Specific Dosing by Indication

Opioid Dependence

  • Initial dose: 25 mg once daily 1
  • Monitor for withdrawal signs
  • If tolerated without withdrawal, advance to 50 mg once daily 1
  • This 50 mg daily dose provides adequate blockade of parenterally administered opioids 1

Alcohol Dependence

  • Standard dose: 50 mg once daily 1
  • This dosing regimen demonstrated efficacy in placebo-controlled trials for up to 12 weeks 1
  • Alternative dosing for supervised administration: 50 mg weekdays with 100 mg Saturday, or 100 mg every other day, or 150 mg every third day 1
  • Caution: Doses above 50 mg carry higher risk of hepatocellular injury 1

The 2013 American Family Physician guideline confirms these dosing recommendations, noting naltrexone is available as 50 mg tablets taken daily, or alternatively 100 mg on Mondays/Wednesdays and 150 mg on Fridays, with a 380 mg monthly injection (Vivitrol) also available. 2

Essential Monitoring and Safety Considerations

Liver function tests should be obtained at baseline and every 3-6 months, as naltrexone has been associated with hepatocellular injury at supratherapeutic doses. 2

Contraindications:

  • Active opioid use or dependence (risk of precipitated withdrawal)
  • Acute opioid withdrawal
  • Current need for opioid analgesics
  • Acute hepatitis or liver failure
  • Positive urine opioid screen 1

Common side effects include nausea (particularly in younger patients, females, and those with shorter abstinence periods), headache, dizziness, and arthralgia. 3, 4 Nausea risk is higher with shorter abstinence duration before starting naltrexone, especially in lighter drinkers. 4

Clinical Context and Effectiveness

Naltrexone works as a mu-opioid receptor antagonist, blocking the euphoric effects of opioids and reducing alcohol craving. 2 However, its effectiveness is highly dependent on patient motivation and comprehensive treatment programs—it should never be used as monotherapy. 1

For alcohol dependence, naltrexone has shown benefit in maintaining abstinence when combined with counseling, though evidence quality varies. 5, 6 The 2010 Hepatology guideline on alcoholic liver disease recommends naltrexone or acamprosate in combination with counseling to decrease relapse likelihood in patients who achieve abstinence. 5

For opioid dependence, naltrexone has demonstrated effectiveness primarily in highly motivated populations (such as healthcare professionals), with more limited success in general populations. 2 Patients discontinuing naltrexone face increased risk of opioid overdose due to decreased tolerance. 2

Critical pitfall: Naltrexone cannot be used in patients requiring opioid pain management, as it will block analgesic effects and potentially precipitate withdrawal in opioid-dependent individuals. 2 For perioperative management, oral naltrexone should be held 2-3 days before surgery if opioids will be needed; extended-release naltrexone requires 24-30 days. 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.